AXIM Biotech Expands Patent Protection on Cannabinoid Chewing Gum -- SECFilings.com
(firmenpresse) - REDONDO BEACH, CA -- (Marketwired) -- 11/17/16 -- SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article on a new, extended patent for AXIM® Biotechologies'' (OTCQB: AXIM) cannabinoid-based chewing gum.
AXIM®, a leader in hemp-based cannabinoid research and development, recently announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for Patent 9,433,601 covering the use of all cannabinoids in cannabinoid-containing controlled-release chewing gum products. The patent represents an extension of its existing Patent 9,023,322 covering medicinal, functional chewing gum as a delivery mechanism for cannabidiol (CBD).
The new patent expands the company''s patent protection from just CBD to at least 85 different cannabinoid compounds found in the cannabis plant -- including THC. The patent could become increasingly valuable over time as research confirms the potential for various cannabinoids to treat medical conditions ranging from chronic pain to cancer. The company holds the exclusive rights to use chewing gum as a delivery mechanism for these treatments.
Chewing gum represents an innovative delivery mechanism with proven benefits. For example, nicotine gum has been used for years as a preferred release mechanism that enables users to carefully control dosing over time. Smokers may only experience cravings at certain times and they can satisfy those cravings with chewing gum rather than receiving a steady dose of nicotine over time that may or may not be needed with patches.
Tetrahydrocannabinol -- or THC -- has similar issues with dosing across patient populations. The right amount of THC depends largely on an individual''s metabolism and experience, which means that chewing gum could be a great way to control dosing relative to patches that deliver a constant dose. Chewing gum also enables individuals to achieve an extended and controlled release of THC or other cannabinoids, which may not be possible with edibles or smoke-able mechanisms.
The act of mastication (chewing) has its own benefits that are not present in other delivery formats. For example, it is well researched that the act of chewing has neuroprotective properties such as increase of blood flow through the middle cerebral artery, and the release of "reward" hormones such as dopamine, serotonin and acetylcholine. It improves the short- and long-term memory and concentration and reduces stress by providing a eustress condition. It also shortens the pituitary supra-renal axis. The act of chewing also is a form of a physical exercise that addresses the sedentary life style of the majority of the population in the industrialized world and especially those with neurodegenerative diseases. In short, AXIM''s delivery system is the only one of its kind where 1+1 equals more than 2.
Follow the link to read the full article:
Founded in 2004, SECFilings.com provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: .
SECFilings.com
Paul Archie
406-862-2242
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.11.2016 - 08:14 Uhr
Sprache: Deutsch
News-ID 1470778
Anzahl Zeichen: 2027
contact information:
Contact person:
Town:
REDONDO BEACH, CA
Phone:
Kategorie:
Alternative
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 255 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"AXIM Biotech Expands Patent Protection on Cannabinoid Chewing Gum -- SECFilings.com
"
steht unter der journalistisch-redaktionellen Verantwortung von
SECFilings.com (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
